南风股份 reported revenue of ¥0.21B for the period ended 2026-06-30, -22.9% year on year. Net income was ¥-0.01B, a -3.5% net margin on a 21.0% gross margin. The largest revenue line is 通风与空气处理系统设备 at 99% of the total. Free cash flow for the period was ¥-0.09B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.21B | -22.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -131.3% |
| Gross margin | 21.0% | Net margin -3.5% |
| Revenue Q/Q | +40.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 通风与空气处理系统设备 | ¥0.21B | 98.9% |
| 3D打印服务 | ¥0.00B | 1.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.17B | 79.0% |
| R&D | ¥0.01B | 5.7% |
| SG&A | ¥0.03B | 16.5% |
| Tax & other | ¥-0.00B | -0.3% |
| Item | Amount |
|---|---|
| Total assets | ¥2.10B |
| Total liabilities | ¥0.33B |
| Shareholders' equity | ¥1.77B |
| Equity / assets | 84.5% |
| Operating cash flow | ¥-0.08B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.09B |
| Cash conversion (OCF / net income) | 1903% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies